Cite
[Hepatic dysfunction and hyperfibrinogenemia in renal adenocarcinoma].
MLA
Pujol Bosch, F., et al. “[Hepatic Dysfunction and Hyperfibrinogenemia in Renal Adenocarcinoma].” Revista Clinica Espanola, vol. 171, no. 5, Dec. 1983, pp. 325–27. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=6669761&authtype=sso&custid=ns315887.
APA
Pujol Bosch, F., Aurteneche Goiriena, J. J., López García, J. A., Sanz Jaka, J. P., & Arocena Lanz, F. (1983). [Hepatic dysfunction and hyperfibrinogenemia in renal adenocarcinoma]. Revista Clinica Espanola, 171(5), 325–327.
Chicago
Pujol Bosch, F, J J Aurteneche Goiriena, J A López García, J P Sanz Jaka, and F Arocena Lanz. 1983. “[Hepatic Dysfunction and Hyperfibrinogenemia in Renal Adenocarcinoma].” Revista Clinica Espanola 171 (5): 325–27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=6669761&authtype=sso&custid=ns315887.